facebook pixel


CARB-X Funds Techulon to Support the Development of Innovative Nano Therapeutics Capable of Killing Drug-Resistant Bacteria by Precisely Targeting Essential Genes 

Techulon project is the 50th project funded by CARB-X since it was launched in 2016. (BOSTON, MA)  – CARB-X is awarding Techulon Inc., located in the Virginia Tech Corporate Research Center in Blacksburg, VA, USA, up to $785,000 in non-dilutive funding to develop a new class of antimicrobial that would kill drug-resistant bacteria by targeting […]